Previously reported linkage of bipolar affective disorder to DNA markers on chromosome 18 was reexamined in a large sample of German bipolar families. Twenty-three short tandem repeat markers were investigated in 57 families containing 103 individuals with bipolar I disorder (BPI), 26 with bipolar II disorder (BPII), nine with schizoaffective disorder of the bipolar type (SA/BP), and 38 individuals with recurrent unipolar depression (UPR). Evidence for linkage was tested with parametric and non-parametric methods under two definitions of the affected phenotype. Analysis of all 57 families revealed no robust evidence for linkage. Following previous reports we performed separate analyses after subdividing the families with respect to the sex of the transmitting parent. Fourteen families were classified as paternal and 12 families as maternal. In 31 families the parental lineage of transmission of the disease could not be determined ('either' families). Evidence for linkage was obtained for chromosomal region 18p11.2 in the paternal families and for 18q22-23 in the 'either' families. The findings on 18p11.2 and 18q22-23 support prior evidence for susceptibility loci in these regions. The parent-of-origin effect on 18p11.2 is confirmed in our sample. The delineation of characteristics of 'either' families requires further study.
Although the etiology of bipolar affective disorder is unknown, strong support for an important genetic component comes from the results of family, twin, and adoption studies. 1 Linkage studies of bipolar disorder to date have provided suggestive evidence in favor of locus heterogeneity. Promising chromosomal regions suggested by recent linkage studies include regions on chromosome 18.
Berrettini et al 2 first reported linkage of bipolar disorder to a region near the centromere on chromosome 18p in 22 families using the affected-sib-pair (ASP) method and the affected-pedigree-member (APM) method. Parametric LOD score analysis of all 22 families revealed negative LOD scores. However, individual families yielded LOD scores Ͼ1 assuming dominant or recessive genetic models. Confirmatory evidence for a bipolar susceptibility locus in this chromosomal region was found by Stine et al. 3 Both parametric LOD score analysis and ASP analysis supported linkage in their study of 28 families. In addition, the same study reported a second susceptibility locus on the long arm of chromosome 18 (18q21). Interestingly, linkage to loci on both 18p and 18q was strongest in those families, in which the father or one of the father's siblings was affected, suggesting a parent-of-origin effect operating in bipolar disorder. Gershon et al 4 re-analyzed the 18p marker data of Berrettini et al 2 by the sex of the transmitting parent. Although no kindred with limited paternal transmission was observed, ASP analysis yielded highly significant excess allele sharing in the pedigrees with mixed maternal-paternal transmission (in different pedigree branches) but not in pedigrees with exclusively maternal transmission confirming the observation of Stine et al. 3 Further evidence for a bipolar susceptibility locus on the long arm of chromosome 18 was provided by four recent linkage studies. Freimer et al 5 analyzed two large Costa Rican families. Linkage disequilibrium based methods suggested a locus in 18q22-23, whereas the LOD score analysis provided only weak support for the presence of linkage. De bruyn et al 6 found linkage of bipolar disorder to markers in 18q21.33-q23 in a large Belgian family using both LOD score and ASP analyses. Coon et al 7 obtained weak evidence for linkage at 18q23 in a sample of 13 families from Utah. LOD score analyses revealed positive LOD scores for three markers in this region. No positive results were obtained with APM and ASP analyses. Using LOD score analysis, Ewald et al 8 reported linkage of markers to a more proximal part on the long arm of chromosome 18 (q12) in two Danish families. In a study of a 30-family sample, McMahon et al 9 obtained confirmatory evidence for a locus at 18q21 using ASP analysis. A parent-of-origin effect was observed, but it was not consistently paternal. No strong evidence for a potential locus on chromosome 18 was found in the recent collaborative NIMH study on bipolar affective disorder. 10 Only one marker at chromosome 18p11.2 and one marker at 18q23 yielded a slight elevation in allele sharing. It is clear from simulations of additive oligogenic inheritance that expectations of universal agreement regarding reported linkages to bipolar disorder are unrealistic. 11 Suarez et al 11 
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have shown that a much smaller family sample may be sufficient to initially detect linkage to one of the trait loci than to replicate linkage to that locus. Therefore, it might not be unexpected that some other studies have not been able to support linkage with chromosome 18. [12] [13] [14] [15] [16] On the other hand, linkage results must be replicated to be credible. If results from two or more independent studies provide significant evidence for linkage in independent series of pedigrees, it is reasonable to assume validity. 17 In the current study we wanted to test the validity of the recent linkage reports investigating a large series of 57 small to moderate German pedigrees. We analyzed 23 microsatellite markers from chromosome 18. The majority of markers were localized on 18p11.2 and 18q21.2-q23; the regions on chromosome 18 being most consistently implicated by previous studies.
LOD score analysis
Twenty-three markers were genotyped on chromosome 18. The LOD scores are shown in Table 1 . Overall twopoint LOD scores did not exceed 1.0 for either model, except for marker D18S37 (1.08 at = 0.1) under a recessive genetic model and ASM II. When we divided the pedigrees into maternal, paternal, and 'either' families, LOD scores Ͼ1 were seen in the paternal families for markers D18S453 (1.91 at = 0.0), D18S37 (1.67 at = 0.0), and D18S40 (1.65 at = 0.01) under a recessive genetic model and ASM I, and for D18S53 (1.06 at = 0.0) under a dominant genetic model and ASM I. Under a recessive model and ASM II, marker D18S453 yielded a LOD score of 1.34 at = 0.0. In the maternal families LOD scores were below 1.0 for all models. In the 'either' families LOD scores Ͼ1 were obtained for D18S469 (1.17 at = 0.0) and D18S70 (1.12 at = 0.05) under a dominant model and ASM II, for D18S554 (1.59 at = 0.05) and D18S70 (1.65 at = 0.05) under a dominant model and ASM I, and for D18S554 (1.26 at = 0.1) and D18S70 (1.09 at = 0.1) with a recessive model and ASM I.
Parametric multipoint LOD score analyses showed peaks in the same regions where two-point LOD scores Ͼ1 had been observed ( Figure 1 ): a LOD score of 2.54 was observed in the paternal families at markers D18S37, D18S453, and D18S40 using a recessive genetic model and a stringent phenotype definition. The non-parametric Z-all score in this region peaked at 1.34 (P = 0.03) (Figure 1 ). For the 'either' families, we obtained a maximum parametric LOD score of 2.1 at markers D18S554 and D18S461 under a dominant model and ASM I. The Z-all score was 2.20 (P = 0.0006) (Figure 1 ).
Affected-sib-pair analysis
ASP analyses in all families showed excess allele sharing for D18S40 (P = 0.035) under ASM II and a nonsignificant trend for flanking markers. In the paternal and maternal families, we observed excess allele sharing for the following markers: D18S453 (P = 0.054) under ASM II in the paternal pedigrees and D18S36 (P = 0.0064) under ASM II in the maternal pedigrees. In the 'either' families, we found excess allele sharing for D18S71 under ASM II. Using ASM I excess allele sharing was observed for D18S554 (P = 0.017) and D18S70 (P = 0.032).
Many reports of linkage in psychiatric disorders have been published in recent years. Interpretation of these findings is difficult and requires critical consideration of the study design, eg power of the family sample, informativity of markers, and statistical methods. The application of statistical thresholds 17 as guidelines for the interpretation of linkage findings alone may not be sufficient to reflect the complex situation in multifactorial disease. 18, 19 Therefore, until susceptibility genes are identified, replication of linkage findings will be the most important criterion to assess their validity.
Although in our study LOD scores failed to reach 3, our results do seem to provide some support for the existence of susceptibility loci on both the short and long arm of chromosome 18. Interestingly, positive findings were obtained after subdividing the families according to the gender of the disease-transmitting parent. Our linkage data support the modest evidence for linkage with markers on 18p11.2 originally reported by Berrettini et al. 2, 20 In accordance with the results of Stine et al 3 and Gershon et al 4 we found the highest LOD scores in the subset of paternal families. Moreover, our multipoint LOD score peaked at the same loci (D18S37, D18S453, D18S40; Figure 1 ) where Gershon et al 4 and Stine et al 3 found their highest LOD scores on 18p11.2. Thus, this is the third study with a large family sample to find evidence for a susceptibility locus for bipolar disorder in a relatively narrow region on the short arm of chromosome 18. Interestingly, in the collaborative NIMH study the marker D18S40 was the only marker on 18p which showed significantly elevated allele sharing. 10 Unfortunately, no data have yet been published from this sample where the sample was subdivided according to the sex of the transmitting parent.
A paternal effect operating in bipolar disorder is also supported by clinical data. [21] [22] [23] Grigoroiu-Serbanescu et al 21 found that paternal transmission of the disease was associated with a significantly younger age of onset of bipolar illness in probands. McMahon et al 23 observed an increased rate of major affective disorder among maternal relatives and a higher than expected proportion of families with no paternal transmission.
A possible biological explanation for the paternal effect observed in the linkage studies is that a susceptibility gene on 18p underlies genomic imprinting. An alternative explanation might be differences between male and female recombination rates on chromosome 18.
3,24,25 Given a simple fully penetrant dominant or recessive mode of inheritance, it is clear that different allele sharing should occur in paternal and maternal families, simply if the male and female recombination rates between disease and marker locus are different. If, for instance, the male recombination rate is higher than the female recombination rate, one would expect higher sharing in the maternal families for a dominant model and higher sharing in the paternal families for a recessive model. Under a dominant model, information about linkage between disease and marker locus mainly comes from the transmission of marker alleles from the affected parent to the affected sibs. That means that the information about linkage is in the transmission from father to affected sib in paternal families and in the transmission from mother to the affected children in the maternal families. If we now assume the male recombination rate to be higher, more evidence for linkage is expected to come from the maternal families since here the recombination rate for the relevant transmissions is lower. If a recessive mode of inheritance is assumed, information is mainly contributed by the non-affected parent (ie, from the paternal side in the maternal families and vice versa). Consequently, in this situation a higher male recombination rate will reduce the sharing rate in the maternal families.
To investigate the potential effect of different recombination rates we performed a simulation study. Based on the genetic models used in our analyses we generated 1000 simulations of 100 extended sib pair families. In addition to the marker and disease information of the affected sibs and their parents we assumed to have disease information on the grandparents. This imitates the real situation where in the case when both parents are unaffected the disease status of grandparents is used to assign a family to the paternal or maternal group, respectively. In our simulations we assumed a male recombination rate of 5% and a female recombination rate of 20%. Table 2 shows the allele sharing observed in the different types of families (paternal, maternal, and either families). As expected, allele sharing was higher in paternal families for the dominant models and higher in maternal families for the recessive models. However, when we looked at the power to detect a significant deviation from random allele sharing we found that the power was always higher in the combined data set than in the different subsamples (Table 2 ). In addition to the evidence given by the simulation study there are other arguments that the positive findings in paternal pedigrees are not simply due to sex differences in recombination. If the findings were caused by this mechanism, one would expect a plethora of falsely positive linkage reports in this region of 18p and not expect an inflation in the Dominant broad 64% ± 7% 57% ± 7% 58% ± 6% 59% ± 5% 71% 30% 40% 83% Dominant narrow 69% ± 5% 59% ± 6% 64% ± 7% 64% ± 3% 96% 45% 66% 99% Recessive broad 60% ± 9% 63% ± 8% 61% ± 5% 61% ± 4% 39% 53% 77% 93% Recessive narrow 63% ± 10% 70% ± 9% 75% ± 4% 72% ± 3% 50% 75% 100% 100% number of negative linkage reports, because such linkage studies would presumably detect the same increased non-specific allele sharing. But several such negative reports have appeared. [12] [13] [14] [15] [16] Also, when the male and female recombination rates are compared across different regions of chromosome 18, the largest discrepancies occur on 18q. 24, 25 Discrepancies on 18p near the centromere are much smaller. Our linkage analyses of markers from the long arm of chromosome 18 provide some support for a second susceptibility locus for bipolar disorder on chromosome 18. The chromosomal region 18q22-23 has originally been proposed by Freimer et al 5 who studied two large pedigrees from a genetically homogeneous population in Costa Rica. Their systematic genome screen revealed three markers on chromosome 18 (D18S64, D18S61, and D18S1161) that exceeded a LOD score threshold of 1.6. Fine mapping in this region with additional markers using association analyses produced significant P-values for D18S469, D18S554, D18S461, and D18S70. Except for D18S461, these markers yield LOD scores Ͼ1.0 in the 'either' subgroup of our family sample as well. Allele sharing IBD was Ͼ50% for all four markers with significant P-values for D18S554 and D18S70.
Surprisingly, evidence for linkage to 18q22-23 is restricted to the 'either' subgroup of our families. A comparison of results between paternal and 'either' families reveals opposite findings for these two subgroups. While the paternal families are linked to 18p11.2 and display exclusion of linkage to 18q22-23, we observe exclusion of linkage to 18p11.2 in the 'either' families and evidence for linkage to 18q22-23. A possible interpretation of these results is that two different genetic transmission patterns are separated to a considerable extent by the division of pedigrees into maternal, paternal, and 'either' families. Initially, we simply considered the 'either' families a sample which could not be classified into maternal or paternal families. However, if the 'either' families were just a mixture of paternal and maternal families that cannot be separated because of limited pedigree size we would actually not expect the observed positive linkage finding on 18q22-23. Neither paternal nor maternal families give evidence for linkage in this area which makes it unlikely that a mixture of both produces a positive result. Comparison of the family structures between the subgroups shows that the parent's affection status is a prominent difference: in contrast to maternal or paternal families where in most cases one parent is affected, the main proportion of the 'either' subgroup (27 out of 31 families) represents families where none of the probands' parents has a psychiatric diagnosis that is included in our disease models. This prominent family structure in the subgroup of 'either' families may reflect a recessive gene action. Surprisingly, we found the most significant results using a dominant inheritance model. Further studies of independent family samples may help to clarify this issue. Of course, there may be other, not yet recognized characteristics that distinguish between 'either' and maternal/paternal families.
In accordance with Freimer et al, 5 De bruyn et al, 6 and Coon et al 7 3 reported evidence for two bipolar susceptibility loci on chromosome 18. The exact location of the putative disease locus on 18q may be difficult to determine due to genetic heterogeneity and the probably low relative risk conferred by this locus. Therefore, the possibility cannot be ruled out that all linkage studies on 18q detect the same disease locus. Indeed, subsequent ASP analyses of the Costa Rican kindreds 26 revealed nominally significant allele sharing at D18S64, one of the most significant markers in the report by Stine et al. 3 We note that our linkage findings on chromosome 18 should be interpreted in the light of statistical testing on the two genetic models and the two affected status models. Likewise, the same data are scrutinized using several analytical methods. Clearly, multiple testing has an inflationary impact on P levels. However, we believe that there is no clear way of correcting for these effects, which are common to many linkage analyses of complex traits.
Any single study will be insufficient to provide convincing proof for a susceptibility locus in a complex disease because of unknown mode of inheritance, genetic heterogeneity, and nongenetic factors. Although our results do not allow definitive conclusions, they are consistent with the hypothesis that susceptibility loci are present on the short and long arm of chromosome 18. It might well be that for a complex disease such as manic depression it would be unrealistic to expect to obtain much stronger evidence from a data set of this size and that definitive conclusions will need to be based on consideration of results from many independent sources.
Material and methods

Family ascertainment
Families were recruited in six clinical centers (Wü rzburg, Mainz, Haar, Dresden, Mü nchen, Bonn) in Germany. Standard diagnostic definitions for ascertainment and extension are the following: bipolar I (BPI), schizoaffective, bipolar type (SA/BP), unipolar, recurrent (UPR), unipolar, single episode (UPS) and other minor psychiatric disorders are defined by DSMIII-R criteria; 27 bipolar II (BPII) by Research Diagnostic Criteria (RDC) 28 with the modification that it requires recurrent episodes of depression. The diagnosis of BPII cannot be made in DSMIII-R, but is made in RDC. We additionally specified that depression be recurrent because of concerns about the reliability of hypomania and single-episode major depression. 29 Inclusion criteria for the systematically ascertained BP families were: (1) a proband with BPI and admission to one of the treatment facilities screened; (2) a secondary affected sib with either BPI, BPII, SA/BP, or UPR; and (3) availability of both parents or-if only one parent was accessible-availability of at least two more sibs from the sibship of the proband.
All individuals were interviewed by an experienced psychiatrist using the Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L). 30 Best estimate diagnoses were based on the interview, review of all available clinical records and family history information.
Description of families
The family sample consisted of 385 individuals from 57 families. None of these families had previously been included in a linkage study with markers from chromosome 18. Results from a subsample of the present sample have previously been published for markers on chromosome 12. 31 The mean number of individuals per pedigree was 6.8. The distribution of diagnoses was as follows: 103 individuals with BPI, 26 individuals with BPII, nine individuals with SA/BP, 38 individuals with UPR, and 38 individuals with a minor psychiatric diagnosis. One hundred and seventy-one individuals were unaffected.
Except for five families (WUE49, WUE67, WUE78, MAI18, HAA117), there were no families where both parents of the index case had a psychiatric diagnosis. In family WUE49, the father had a diagnosis of BPI, and the mother had a diagnosis of UPR. The father of family WUE78 displayed an adjustment disorder with depressed mood, the mother had UPS. The father of family WUE67 had UPR, the mother was BPI. In family MAI18 the father was diagnosed with UPS, the mother with BPII. Both father and mother of family HAA117 had a personality disorder. There were 14 'paternal families', in which the father of the proband, the grandfather or grandmother on the paternal side or at least one of the father's sibs was affected with BPI, BPII, SA/BP, or UPR, respectively. Similarly, we classified 12 families as 'maternal'. For the remaining 31 families, the parental lineage of transmission of the disease could not be determined. These families were designated 'either' families. Twenty-seven of these families could not be classified, because none of the parents was affected and there were no parental relatives available or there were no affected relatives in either parental lineage. In two of the families with two or more branches (MA121, DRE19), we observed both maternal and paternal transmission of the disease and therefore classified them 'either'. The four families with both parents of the index case having a psychiatric diagnosis were classified as follows: families WUE49, WUE78, and HAA117 were treated as 'either' families, MAI18 was a maternal family. 
DNA isolation and cell lines
EDTA anticoagulated venous blood samples were collected from 320 individuals who were available for the study. Leukocyte DNA was isolated as described. 32 Whenever possible, leukocytes were isolated and transformed using Epstein-Barr virus in order to establish permanent cell lines.
Genotyping
Complete genotypic data were collected from 320 individuals. We studied 23 short tandem repeat (STR) markers on chromosome 18 (PACAP, D18S62, D18S53,  GOLF, D18S71, D18S37, D18S453, D18S40, D18S44,  D18S36,  D18S39,  D18S41,  D18S64,  D18S38,  D18S1147, D18S68, D18S392, D18S541, MBP,  D18S469 , D18S554, D18S461, D18S70). Markers D18S64, D18S68, D18S469, and D18S70 were taken from the ABI Prism Linkage Mapping Set (Applied Biosystems, Foster City, CA, USA). Information on primer sequences for all other markers was taken from published marker maps [33] [34] [35] (Genome Data Base Version 5.6).
One oligonucleotide of each pair of PCR primers was fluorescein labeled. The PCR reaction for each marker was carried out in a 10-l volume containing 40 ng genomic DNA, 5 pmol of each primer, 200 M of each dNTP, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5-2.5 mM MgCl 2 , and 0.6 U Taq polymerase (Life Technologies, Rockville, MD, USA). After an initial denaturation of 5 min at 95°C, 33 cycles of amplification of 15 s at 94°C, 15 s at 55-62°C, and 30 s at 72°C were performed in a Perkin Elmer 9600 thermocycler. The resulting amplified products were separated on 4% denaturing polyacrylamide gels on an automated DNA sequencer (Model 377, Applied Biosystems). Allele sizes were determined relative to an internal size standard in each lane using Genescan Analysis and Genotyper software (Applied Biosystems). In addition, a reference individual with known genotype was loaded on each gel. All gels were scored independently by two individuals who were blind to the disease status. Each marker in every family was tested for Mendelian inheritance.
Linkage analyses
Two models of affection were used in the linkage analyses: affection status model (ASM)-I (narrow definition of the phenotype) included only individuals with BPI as affected, all other psychiatric diagnoses were coded as 'unknown'; ASM II (broad definition) included all individuals with a diagnosis of BPI, BPII, SA/BP, and UPR with UPS and other minor psychiatric disorders coded 'unknown'.
There are about 115 ASPs in our 57 pedigrees. This number of ASPs has a power greater than 90% to detect linkage ( Յ 0.05) at a level ␣ = 5% under ASM II (recessive and dominant) if at least 50% of the kindreds are linked to a single locus.
Two-point LOD scores were calculated by means of MLINK and ILINK programs of the LINKAGE package. 36 All analyses were conducted using an 'affectedsonly' approach. For both disease definitions the LOD scores were calculated assuming both a dominant and a recessive mode of inheritance. Under the broad affection model we assumed a phenocopy rate of 3.2% and a penetrance of 50% under both genetic models. The frequency of the disease allele was set to 24.5% and 3% for the recessive and dominant genetic model, respectively. For the narrow affection model the phenocopy rate was set to 0.1%, penetrance was assumed to be 50% and the frequency of the disease allele was set to 13.4% under recessive and to 0.9% under dominant mode of inheritance. These assumptions correspond to a lifetime morbid risk of 6% for diseases included in ASM II and of 1% for BPI (ASM I). 37 An age-dependency of the penetrance was not taken into account, since using 'affecteds-only' treats unaffected individuals as phenotype unknown, which diminishes the effect of quantifying the correct penetrance.
The P-values for allele sharing between affected sibs were derived by comparing the observed sharing rate for a marker with the exact distribution of allele sharing expected under the null hypothesis of no linkage given the number and size of sib-ships which were informative of the marker. The (one-sided) P-value was taken as the probability to have the observed or a higher sharing rate under the null hypothesis.
Multipoint LOD scores as well as nonparametric multipoint analyses were performed using the GENE-HUNTER program Version 1.1. 38 For the multipoint LOD score analysis, the same models as for the twopoint analysis were used (dominant and recessive mode of inheritance, narrow and broad disease model). For non-parametric multipoint linkage analysis both pairwise identical by descent (IBD), allele sharing (Zpairs) and IBD sharing among all affected family members (Z-all) was calculated. Only results from the Z-all statistics are given because testing whether the same allele is found IBD in many affected relatives is a more powerful strategy than considering one relative pair at a time. 38 acknowledge the expert help of the following psychiatrists Dres. Judith Kö rner, Mario Lanczik, and Ulrike Reuner. This collaborative study was supported by the DFG Schwerpunktprogramm 'Genetische Faktoren bei psychiatrischen Erkrankungen'.
